Open Accessibility Menu

Massive Valsartan Recall Further Expanded by the FDA

Jason Reese

FDA Widens Valsartan Recall Due to Cancer Risk

A drug recall is often seen as an effective way to protect the public from potentially harmful products; but what happens when the damage has already been done? Attorneys at Wagner Reese are investigating the FDA’s recent recall of certain blood pressure medications containing Valsartan, the generic form of Diovan, due to the risk of a cancer-causing impurity. The FDA recall comes after 22 other countries issued recalls for these drugs.

The specific products initially identified by the FDA in their July 18, 2018 press release included valsartan-containing medications from Major Pharmaceuticals, Teva Pharmaceuticals, and Solco Healthcare LLC. The recalled product list was recently expanded to include products from several additional companies not previously named, including Actavis, AvKARE, Remedy Repack, A-S Medication Solutions LLC, Bryant Ranch Prepack, Inc., HJ Harkins Company Inc. dba Pharma Pac, Proficient Rx LP, Northwind Pharmaceuticals, Camber Pharmaceuticals, Inc., and NuCare Pharmaceuticals Inc. Follow this link for the full FDA list of recalled drugs.

In addition to the list of recalled drugs, the FDA has also provided a list of Valsartan products that are not currently under recall. It is important to continue checking the FDA website as their investigation continues and the list of recalled products is updated.

My blood pressure medication has been recalled – what do I do?

Begin by looking at the prescription bottle to determine if the drug name and company name match the list of drugs recalled by the FDA, linked in the paragraph above. Not all valsartan containing products are being recalled at this time, as not all drugs may contain the NDMA impurity that could put users at an increased cancer risk.

Most importantly, talk with your prescribing doctor if you have concerns. Valsartan alternatives are available, and it is crucial that patients speak with their physicians before discontinuing any medications. This is especially true for valsartan containing medications, which treat serious conditions such as heart failure and high blood pressure. Abruptly stopping these products could cause patients serious harm.

Many pharmacies are sending out letters to notify those affected by the recall. We recommend saving any recall notice letters that you or loved ones receive, as well as any medication or bottles in your possession that are subject to the recall.

Know your rights

Wagner Reese attorneys are investigating the Valsartan recall and are representing dozens of clients affected by the recalled medication. Contact our office at (888) 204-8440 for a free consultation if you or a loved one may have been negatively affected by Valsartan medication.


Request Your Free Case Evaluation

Fill out the form below to get started or give us a call at (888) 204-8440 to speak with our legal team directly.

  • Please enter your First Name.
  • Please enter your Last Name.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • This isn't a valid email address.
    Please enter your email address.
  • Please make a selection.
  • Please enter a message.

Our Locations

  • Indianapolis Office: 201 N. Illinois St.,
    16th Floor - South Tower

    Indianapolis, IN 46204
  • Carmel Office: 11939 N. Meridian St.
    Carmel, IN 46032
  • Evansville Office: 815 John St. Suite 110
    Evansville, IN 47713
  • Fort Wayne Office: 3201 Stellhorn Rd
    Fort Wayne, IN 46815
  • Champaign Office: 701 Devonshire Dr., Suite C17
    Champaign, IL 61820